Because AR and ER share similar ChIP-seq binding profiles [19–21], it was concluded that in the presence of ER, AR interacts with estrogen response elements, thereby blocking the expression of downstream estrogen target genes and inhibiting ER-stimulated tumor growth. The gene discussed is ESR1; the disease is neoplasm.